All In MedTech

Device Trial Radar · NCT00839384

AdvisaTM IPG Clinical Evaluation Study

Clinical Study to Evaluate System Safety and Clinical Performance of the AdvisaTM IPG

Last checked: Nov 19, 2026Latest source record: Jul 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

79

Actual

Start

Feb 2009

Primary completion

Jul 2009

Study completion Jul 2009

Sponsor

Sponsor type
Industry
Collaborators
Medtronic
First posted
Feb 9, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the Advisa IPG clinical study is to evaluate the overall system safety and clinical performance of the Advisa DR Implantable Pulse Generator (IPG).

Conditions

  • Bradycardia
  • Atrial Tachyarrhythmia

Interventions

  • Advisa IPGDevice

    Implantable Pulse Generator will be implanted

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. USADE at 1 month post implantTime frame: 1 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • IKEM

    Prague, Czechia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.